https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-09-01 / Ceska Gynekol 2004 Sep;69(5):372-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-09-01 / Ceska Gynekol 2004 Sep;69(5):372-52004-09-01 00:00:002004-09-01 00:00:00[Immunotherapy–perspectives in therapy of ovarian carcinomas]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-04-01 / Int. J. Clin. Oncol. 2004 Apr;9(2):85-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-04-01 / Int. J. Clin. Oncol. 2004 Apr;9(2):85-912004-04-01 00:00:002004-04-01 00:00:00Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-01 / Curr. Opin. Obstet. Gynecol. 2004 Feb;16(1):87-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-01 / Curr. Opin. Obstet. Gynecol. 2004 Feb;16(1):87-922004-02-01 00:00:002004-02-01 00:00:00Immunological treatment of ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-09-01 / Anticancer Res. 2003 Sep-Oct;23(5b):4293-303
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-09-01 / Anticancer Res. 2003 Sep-Oct;23(5b):4293-3032003-09-01 00:00:002019-02-15 08:45:51Dendritic cell-based vaccines in breast and gynaecologic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Clin. Cancer Res. 2003 Apr;9(4):1517-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Clin. Cancer Res. 2003 Apr;9(4):1517-272003-04-01 00:00:002003-04-01 00:00:00TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-01 / Transfus. Apher. Sci. 2002 Oct;27(2):183-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-01 / Transfus. Apher. Sci. 2002 Oct;27(2):183-62002-10-01 00:00:002002-10-01 00:00:00Dendritic cells in vaccination therapies of malignant diseases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Minerva Ginecol 2002 Apr;54(2):133-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Minerva Ginecol 2002 Apr;54(2):133-442002-04-01 00:00:002002-04-01 00:00:00Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-02-01 / Expert Rev Anticancer Ther 2002 Feb;2(1):97-105
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-02-01 / Expert Rev Anticancer Ther 2002 Feb;2(1):97-1052002-02-01 00:00:002002-02-01 00:00:00Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-10 / Cancer Immunol. Immunother. 2002 Mar;51(1):45-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-10 / Cancer Immunol. Immunother. 2002 Mar;51(1):45-522002-01-10 00:00:002019-02-15 08:46:11Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-07 / Br. J. Cancer 2002 Jan;86(1):151-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-07 / Br. J. Cancer 2002 Jan;86(1):151-72002-01-07 00:00:002002-01-07 00:00:00Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
